// App-Quantinova.ai

PB1202 : Monitoring the persistence of vaccine-induced immune thrombotic thrombocytopenia (VITT) antibodies and their pathogenicity

Researchers

Presenter

  • C. Lee

Principal Investigators

  • L. Clarke

  • T. Brighton

  • S. Chunilal

  • E. Favaloro

  • D. Donikian

  • M. Kondo

  • H. Tran

  • V. CHEN

Medical Centers

  • ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia

  • Department of Haematology, Concord Repatriation General Hospital; Australian Red Cross Lifeblood, Sydney Adventist Hospital, Concord, New South Wales, Australia

  • Department Haematology, New South Wales Health Pathology, Prince of Wales Hospital, Sydney, New South Wales, Australia

  • Monash Health, Clayton, Australia

  • Charles Sturt University, NSW Health Pathology, Sydney Centres for Thrombosis and Haemostasis, Sydney, New South Wales, Australia

  • Department of Clinical Hematology, The Alfred Hospital, Melbourne, Australia AND Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia, Melbourne, Victoria, Australia

  • ANZAC Research Institute, University of Sydney; Department of Haematology, Concord Repatriation General Hospital, Sydney, New South Wales, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Thrombocytopenia

  • Venous thrombosis

Biomarkers

  • D-dimer

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A